Prostate cancer (PCa) is one of the main diseases that endanger men’s health worldwide. In developing countries, due to the large number of patients and the lack of medical resources, there is a big conflict between doctors and patients. To solve this problem, an auxiliary medical decision system for prostate cancer was constructed. The system used six relevant tumor markers as the input features and employed classical machine learning models (support vector machine and artificial neural network). Stacking method aimed at different ensemble models together was used for the reduction of overfitting. 1,933,535 patient information items had been collected from three first-class hospitals in the past five years to train the model. The result showed that the auxiliary medical system could make use of massive data. Its performance is continuously improved as the amount of data increases. Based on the system and collected data, statistics on the incidence of prostate cancer in the past five years were carried out. In the end, influence of diet habit and genetic inheritance for prostate cancer was analyzed. Results revealed the increasing prevalence of PCa and great negative impact caused by high-fat diet and genetic inheritance.

Assessing the extent of cancer spread by histopathological analysis of sentinel axillary lymph nodes is an important part of breast cancer staging. With the maturity and prevalence of deep learning technology, building auxiliary medical systems can help to relieve the burden of pathologists and increase the diagnostic precision and accuracy during this process. However, such histopathological images have complex patterns that are difficult for ordinary people to understand and require professional medical practitioners to annotate. This increases the cost of constructing such medical systems. To reduce the cost of annotating and improve the performance of the model as much as possible, in other words, using as few labeled samples as possible to obtain a greater performance improvement, we propose a deep learning framework with a three-stage query strategy and novel model update strategy. The framework first trains an auto-encoder with all the samples to obtain a global representation in a low-dimensional space. In the query stage, the unlabeled samples are first selected according to uncertainty, and then, coreset-based methods are employed to reduce sample redundancy. Finally, distribution differences between labeled samples and unlabeled samples are evaluated and samples that can quickly eliminate the distribution differences are selected. This method achieves faster iterative efficiency than the uncertainty strategies, representative strategies, or hybrid strategies on the lymph node slice dataset and other commonly used datasets. It reaches the performance of training with all data, but only uses 50% of the labeled. During the model update process, we randomly freeze some weights and only train the task model on new labeled samples with a smaller learning rate. Compared with fine-tuning task model on new samples, large-scale performance degradation is avoided. Compared with the retraining strategy or the replay strategy, it reduces the training cost of updating the task model by 79.87% and 90.07%, respectively.

In many countries, lung cancer is the chief cancer type, and the overall survival rate in 5 years remains at a low rate of 16.8%. Among lung cancer patients, the proportion of patients with non-small cell lung cancer (NSCLC) can reach 85%. Especially in developing countries, it has become a great challenge for doctors to diagnose efficiently because of the complex diagnostic process of NSCLC, a large number of patients, and limited medical resources. Based on the above situation, our main objective in this study is to construct an auxiliary Artificial Intelligence medical system for doctors to diagnose the NSCLC patients efficiently. In this research, we select the combination of Support Vector Machine (SVM) and Artificial Neural Network (ANN) to complete the classification and training tasks of the medical system. In this study, we trained and tested our decision model based on the data information of 12,186 patients in three hospitals in China. The results of this experiment show that the accuracy of our system has reached 88% when the amount of data reaches 4000, which is close to that of doctors.